Correlation Between In8bio and Kiora Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both In8bio and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining In8bio and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between In8bio Inc and Kiora Pharmaceuticals, you can compare the effects of market volatilities on In8bio and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in In8bio with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of In8bio and Kiora Pharmaceuticals.

Diversification Opportunities for In8bio and Kiora Pharmaceuticals

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between In8bio and Kiora is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and In8bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on In8bio Inc are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of In8bio i.e., In8bio and Kiora Pharmaceuticals go up and down completely randomly.

Pair Corralation between In8bio and Kiora Pharmaceuticals

Given the investment horizon of 90 days In8bio Inc is expected to generate 1.28 times more return on investment than Kiora Pharmaceuticals. However, In8bio is 1.28 times more volatile than Kiora Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest  221.00  in In8bio Inc on September 1, 2025 and sell it today you would lose (23.00) from holding In8bio Inc or give up 10.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

In8bio Inc  vs.  Kiora Pharmaceuticals

 Performance 
       Timeline  
In8bio Inc 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days In8bio Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, In8bio is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Kiora Pharmaceuticals 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

In8bio and Kiora Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with In8bio and Kiora Pharmaceuticals

The main advantage of trading using opposite In8bio and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if In8bio position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.
The idea behind In8bio Inc and Kiora Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios